Erratum: Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 Patients (The Journal of Urology (2010) 184(3) (888–894) (S0022534710035160) (10.1016/j.juro.2010.04.081));Stage pT0 at radical cystectomy confers improved survival: An international study of 4,430 patients

Journal of Urology

Volumn 184, Issue 3, 2010, Pages 888-894

  Tilki, Derya ^a   Svatek, Robert S ^c   Novara, Giacomo ^f   Seitz, Michael ^a   Godoy, Guilherme ^d   Karakiewicz, Pierre I ^g   Kassouf, Wassim ^h   Fradet, Yves ⁱ   Fritsche, Hans Martin ^b   Sonpavde, Guru ^d   Izawa, Jonathan I ^j   Ficarra, Vincenzo ^f   Lerner, Seth P ^d   Schoenberg, Mark ^k   Stief, Christian G ^a   Dinney, Colin P ^c   Skinner, Eila ^l   Lotan, Yair ^e   Sagalowsky, Arthur I ^e   Reich, Oliver ^a   Shariat, Shahrokh F ^m   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

ⁱ UNIVERSITÉ LAVAL   (Canada)

^j UNIVERSITY OF WESTERN ONTARIO   (Canada)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^m WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

carcinoma; cystectomy; mortality; urinary bladder; urothelium

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BLADDER CARCINOMA; CANADA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYSTECTOMY; DISEASE FREE SURVIVAL; EUROPE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED STATES; AGED; BLADDER TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; MULTICENTER STUDY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 77956627862     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2010.09.043     Document Type: Erratum

References (22)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225
2. J. Ferlay, P. Autier, and M. Boniol Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 2007 581
3. J.P. Stein, G. Lieskovsky, and R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666
4. S.F. Shariat, G.S. Palapattu, and P.I. Karakiewicz Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy Eur Urol 51 2007 137
5. S.F. Shariat, P.I. Karakiewicz, and G.S. Palapattu Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium J Urol 176 2006 2414
6. S. Madersbacher, W. Hochreiter, and F. Burkhard Radical cystectomy for bladder cancer todaya homogeneous series without neoadjuvant therapy J Clin Oncol 21 2003 690
7. R.E. Hautmann, J.E. Gschwend, and R.C. de Petriconi Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era J Urol 176 2006 486
8. G. Dalbagni, E. Genega, and M. Hashibe Cystectomy for bladder cancer: a contemporary series J Urol 165 2001 1111
9. C.L. Amling, J.B. Thrasher, and H.A. Frazier Radical cystectomy for stage Ta, stage Tis and stage T1 transitional cell carcinoma of the bladder J Urol 151 1994 31
10. M. Hotston, S. Patel, and M. Sohail What is the significance of pT0 at cystectomy? Surg Oncol 15 2006 65
11. W. Kassouf, P.E. Spiess, and G.A. Brown P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors Eur Urol 52 2007 769
12. J.B. Thrasher, H.A. Frazier, and J.E. Robertson Does a stage Pt0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer J Urol 152 1994 393
13. R.B. Bracken, D.E. Johnson, and A.C.V. Eschenbach Role of Intravesical mitomycin-c in management of superficial bladder tumors Urology 16 1980 11
14. B.G. Volkmer, R. Kuefer, and G. Bartsch Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival Cancer 104 2005 2384
15. H.B. Grossman, R.B. Natale, and C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859
16. G.S. Palapattu, P.I. Karakiewicz, and P.J. Bastian Are patients who are PT0 following radical cystectomy cured of bladder cancer? Results from the Bladder Cancer Research Consortium (BCRC) J Urol 173 2005 374
17. T.R. Coblentz, S.E. Mills, and D. Theodorescu Impact of second opinion pathology in the definitive management of patients with bladder carcinoma Cancer 91 2001 1284
18. N.A. Mungan, L.A. Kiemeney, and J.A. van Dijck Gender differences in stage distribution of bladder cancer Urology 55 2000 368
19. S.F. Shariat, J.P. Sfakianos, and M.J. Droller The effect of age and gender on bladder cancer: a critical review of the literature BJU Int 105 2010 300
20. R.S. Svatek, S.F. Shariat, and C. Dinney Evidence-based gender related outcomes after radical cystectomy: results of a large multicenter study J Urol 181 suppl. 2009 629 abstract 1744
21. C. Jeldres, H. Isbarn, and U. Capitanio Gender is an important predictor of cancer-specific survival in patients with urothelial carcinoma after radical cystectomy J Urol 181 suppl. 2009 635 abstract 1761
22. G.D. Datta, B. Neville, and N.S. Datta Gender disparities in bladder cancer survival: an assessment of socio-demographic factors AACR Meeting Abstracts 2006 2006 B38